Bergstrom R - Search Results

1

Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.

Mitchell M, Kothare P, Bergstrom R, Zhao F, Jen KY, Walker D, Johnson J, McDonnell D. Mitchell M, et al. Among authors: bergstrom r. Clin Ther. 2013 Dec;35(12):1890-908. doi: 10.1016/j.clinthera.2013.09.023. Epub 2013 Oct 31. Clin Ther. 2013. PMID: 24184052 Clinical Trial.

2

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.

McDonnell DP, Detke HC, Bergstrom RF, Kothare P, Johnson J, Stickelmeyer M, Sanchez-Felix MV, Sorsaburu S, Mitchell MI. McDonnell DP, et al. BMC Psychiatry. 2010 Jun 10;10:45. doi: 10.1186/1471-244X-10-45. BMC Psychiatry. 2010. PMID: 20537130 Free PMC article.

3

Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia.

Kane JM, Detke HC, Naber D, Sethuraman G, Lin DY, Bergstrom RF, McDonnell D. Kane JM, et al. Am J Psychiatry. 2010 Feb;167(2):181-9. doi: 10.1176/appi.ajp.2009.07081221. Epub 2009 Dec 15. Am J Psychiatry. 2010. PMID: 20008947 Clinical Trial.

4

Pharmacokinetics of olanzapine long-acting injection: the clinical perspective.

Heres S, Kraemer S, Bergstrom RF, Detke HC. Heres S, et al. Int Clin Psychopharmacol. 2014 Nov;29(6):299-312. doi: 10.1097/YIC.0000000000000040. Int Clin Psychopharmacol. 2014. PMID: 24815672 Free PMC article.

5

Oral olanzapine disposition in adolescents with schizophrenia or bipolar I disorder: a population pharmacokinetic model.

Lobo ED, Robertson-Plouch C, Quinlan T, Hong Q, Bergstrom RF. Lobo ED, et al. Paediatr Drugs. 2010 Jun;12(3):201-11. doi: 10.2165/11532580-000000000-00000. Paediatr Drugs. 2010. PMID: 20297865

6

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Callaghan JT, et al. Among authors: bergstrom rf. Clin Pharmacokinet. 1999 Sep;37(3):177-93. doi: 10.2165/00003088-199937030-00001. Clin Pharmacokinet. 1999. PMID: 10511917 Review.

7

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.

Bergstrom RF, Peyton AL, Lemberger L. Bergstrom RF, et al. Clin Pharmacol Ther. 1992 Mar;51(3):239-48. doi: 10.1038/clpt.1992.18. Clin Pharmacol Ther. 1992. PMID: 1544284

8

Secretion of nizatidine into human breast milk after single and multiple doses.

Obermeyer BD, Bergstrom RF, Callaghan JT, Knadler MP, Golichowski A, Rubin A. Obermeyer BD, et al. Among authors: bergstrom rf. Clin Pharmacol Ther. 1990 Jun;47(6):724-30. doi: 10.1038/clpt.1990.100. Clin Pharmacol Ther. 1990. PMID: 1972674

9

Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes.

Tohen M, Bowden CL, Smulevich AB, Bergstrom R, Quinlan T, Osuntokun O, Wang WV, Oliff HS, Martenyi F, Kryzhanovskaya LA, Greil W. Tohen M, et al. Among authors: bergstrom r. Br J Psychiatry. 2008 Feb;192(2):135-43. doi: 10.1192/bjp.bp.107.041301. Br J Psychiatry. 2008. PMID: 18245032 Clinical Trial.

10

The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam.

Lemberger L, Rowe H, Bosomworth JC, Tenbarge JB, Bergstrom RF. Lemberger L, et al. Among authors: bergstrom rf. Clin Pharmacol Ther. 1988 Apr;43(4):412-9. doi: 10.1038/clpt.1988.52. Clin Pharmacol Ther. 1988. PMID: 3128416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

578 results

Search Page

Filters